NA
PGEN icon

NewEdge Advisors’s Precigen PGEN Stock Holding History

NewEdge Advisors’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.7K Sell
10,826
-264
-2% -$1.14K ﹤0.01% 3072
2026
Q1 		$42.9K Buy
11,090
+300
+3% +$1.23K ﹤0.01% 2972
2025
Q4 		$45.1K Buy
+10,790
New +$41.7K ﹤0.01% 2986
2017
Q3 		– Sell
-100
Closed -$2.35K – 900
2017
Q2 		$2.35K Buy
+100
New +$2.19K ﹤0.01% 1279

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NewEdge Advisors's PGEN Position: Q2 2026 in Review

NewEdge Advisors reduced its Precigen (PGEN) stake by 2.4% in Q2 2026, selling an estimated $1.14K and leaving 10,826 shares worth $61.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3072.

NewEdge Advisors first reported a position in PGEN in Q2 2017 and has held it in 4 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • NewEdge Advisors held 10,826 shares of Precigen worth $61.7K as of Q2 2026.
  • NewEdge Advisors sold 264 Precigen shares in Q2 2026, an estimated $1.14K.
  • Precigen made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #3072 holding.
  • NewEdge Advisors first reported a position in Precigen in Q2 2017 and has held it in 4 quarters since.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.